Summary of Significant Accounting Policies (Tables)

3 Months Ended

Dec. 31, 2022

Accounting Policies [Abstract]

Schedule of Restrictions on Cash and Cash Equivalents

The following table provides a reconciliation of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.

	December 31, 2022		December 31, 2021
Cash and cash equivalents	$	317	$	334
Restricted cash	227		24
Cash, cash equivalents and restricted cash	$	544	$	358

Schedule of Cash and Cash Equivalents

The following table provides a reconciliation of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.

	December 31, 2022		December 31, 2021
Cash and cash equivalents	$	317	$	334
Restricted cash	227		24
Cash, cash equivalents and restricted cash	$	544	$	358

Schedule of Shares Used in Computing Basic and Diluted Earnings Per Share

Shares used in computing basic and diluted earnings per share are as follows: 

	Three Months Ended December 31,
	2022	2021
Denominator (thousands of shares):
Weighted-average common shares outstanding — basic	209,934	209,673
Incremental shares issuable for stock options, common stock awards and Equity Units (a)	—	—
Weighted-average common shares outstanding — diluted	209,934	209,673

(a)For the three months ended December 31, 2022 and 2021, 6,431 and 6,486, respectively, of such shares have been excluded as these incremental shares would be antidilutive due to the net losses for the periods presented. At December 31, 2022 and 2021, these incremental shares exclude the effects of 6,625 and 3,347 shares, respectively, associated with outstanding stock option awards because their effect was antidilutive.